Vivos Therapeutics, Inc.
VVOS
$2.63
-$0.08-2.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.83M | -2.62M | -1.93M | -3.76M | -4.26M |
| Total Depreciation and Amortization | 144.00K | 146.00K | 145.00K | 146.00K | 149.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 62.00K | 148.00K | 295.00K | 299.00K | 456.00K |
| Change in Net Operating Assets | -319.00K | -1.86M | -1.56M | 802.00K | 906.00K |
| Cash from Operations | -2.94M | -4.19M | -3.05M | -2.52M | -2.75M |
| Capital Expenditure | -165.00K | -192.00K | -60.00K | -151.00K | -165.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -165.00K | -192.00K | -60.00K | -151.00K | -165.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.50M | 4.30M | 7.50M | 3.94M | 4.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -446.00K | -509.00K | -100.00K | -306.00K | -432.00K |
| Cash from Financing | 3.05M | 3.79M | 7.40M | 3.64M | 3.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -51.00K | -592.00K | 4.29M | 968.00K | 655.00K |